NCT00078221Unknown3 期
Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD)
适应症
试验速览
- 阶段
- 3 期
- 发起方
- OccuLogix
- 入组人数
- 180
- 试验地点
- 15
研究概览
简要总结
AMD is a progressive disease of the retina which is nourished by a network of tiny blood vessels. There is evidence to suggest that the flow of nutrients to the retina is impaired in patients with AMD. Rheopheresis blood filtration uses blood filters that deplete excesses of large proteins, fats and other substances from the blood, improving blood flow to the macula, potentially improving vision.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 50 Years 至 85 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Age 50-85
- •Diagnosis of Dry AMD
- •BCVA between 20/32 and 20/125 in at least one eye
- •Numerous large plaques (soft drusen)
- •No history of HIV, Hepatitis B or C
- •Elevation of certain blood factors, such as total cholesterol, fibrinogen, and IgA
排除标准
- 未提供
研究者
研究点 (15)
Loading locations...
相似试验
已完成
不适用
Mechanisms of Retinal Revascularization and Clinical Indicators of Neovascular AMD RelapseWet Macular DegenerationNCT05211804Sorlandet Hospital HF31
已完成
3 期
A Study to Comparing SCD411 and Eylea® in Subjects With Wet Age-related Macular Degeneration (AMD)Wet Age-related Macular DegenerationNeovascular Age-related Macular DegenerationNCT04480463Sam Chun Dang Pharm. Co. Ltd.576
进行中（未招募）
不适用
Ocular, Vascular, and Genetic Findings in AMD PatientsAge-Related Macular DegenerationNCT06015633OcuDyne, Inc.50
已完成
不适用
Surgery, Tissue Plasminogen Activator, Antiangiogenic Agents and Age Related Macular Degeneration ComplicationsSubretinal Haematoma Linked to AMDNCT02557451Centre Hospitalier Universitaire Dijon91
终止
2 期
Open-Label, Pilot Study of TG100801 in Patients With Choroidal Neovascularization Due to AMDChoroidal NeovascularizationMacular DegenerationNCT00509548TargeGen7